Transaction Breakdown
Companies & Roles
Discretionary Trading P&L
Holdings
Transaction History
About NEUPERT PETER M
NEUPERT PETER M (SEC CIK 0001237566) files insider reports with the SEC as Director of Adaptive Biotechnologies Corp (ADPT), Director of Fortrea Holdings Inc. (FTRE) and Director of LABCORP HOLDINGS INC. (LH).
Signal8 holds 12 ownership filings by NEUPERT PETER M, all Form 4s, filed between Feb 10, 2025 and Aug 19, 2026. Those filings report 18 transactions, the latest on Aug 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on NEUPERT PETER M's filings is in SEATTLE, WA.
Other insiders filing for Adaptive Biotechnologies Corp (ADPT)
- RUBINSTEIN JULIE, President and COO
- BOBULSKY SUSAN, Chief Commercial Officer, MRD
- LO FRANCIS, Chief People Officer
- OWEN KATEY EINTERZ, Director
- HERSHBERG ROBERT, Director
- ROBINS CHAD M, CEO and Chairman